Tim delivers innovative and impactful results to clients by leveraging experience across consumer insights, R&D, and commercialization.
Tim is a Principal at Arthur D. Little based in the Boston office and focuses on generating & delivering actionable strategic insights and tangible results to clients across multiple industries.
Tim has significant expertise in end-to-end innovation from quantifying consumer needs to product launch, analytically-based market, technology and competitive assessments, as well as economic and environmental lifecycle analyses.
Prior to joining Arthur D. Little, Tim led both drug discovery and development programs during his tenure at Vertex Pharmaceuticals and Merck Research Labs.
Tim conducted post-doctoral research under the late 2008 Nobel Laureate Professor Roger Tsien in the field of tumor targeting and graduate research under Professor Stephen Buchwald in the fields of organic methodology and mechanistic chemistry.
Tim is a co-author on over 20 peer-reviewed publications and patents, which have garnered nearly 5,000 citations to date.